Functional neurological disorders in hospitalized children and adolescents: a retrospective cohort study

Study Overview

The investigation focused on functional neurological disorders (FNDs) among children and adolescents who were hospitalized, evaluating their prevalence and characteristics within a retrospective cohort framework. FNDs represent a group of conditions where patients experience neurological symptoms that cannot be accounted for by organic disease, leading to significant distress and impairment. Understanding the presentation and outcomes of these disorders in young populations is crucial for developing effective treatment strategies.

This study analyzed a cohort of patients aged 0-18 years who were hospitalized due to symptoms indicative of FNDs over a defined period. The objective was to generate a comprehensive overview of the clinical features, duration of hospital stays, and treatment approaches employed. This cohort was assembled from patient records, ensuring that the data analyzed were representative of actual clinical practice and demographic distributions.

Data were extracted from medical charts and included a variety of parameters, such as age at presentation, gender, length of hospitalization, and symptom types. The study also sought to identify any common comorbidities, previous medical history, and response to treatment during the hospital stay.

The results aimed to shed light on the nuances of FNDs in pediatric patients, as the discrepancies in diagnosis, management pathways, and long-term outcomes are notable in this demographic compared to adults. By gathering and analyzing this data, the research endeavors to contribute vital information that aids in refining both clinical and educational approaches to FNDs in pediatric care settings.

Methodology

The research employed a retrospective cohort study design, allowing researchers to gather and analyze data from existing medical records of children and adolescents diagnosed with functional neurological disorders (FNDs) during a specified time frame. This approach facilitated a comprehensive examination of clinical presentations and treatment responses without the need for new data collection, thereby expediting the analysis process and reducing costs.

Patient records were sourced from a single pediatric hospital, ensuring that the data reflects consistent medical practices within that specific institution. To ensure the cohort’s relevance, the inclusion criteria mandated that participants were between the ages of 0 and 18 years, with documented symptoms indicative of FNDs during their hospital admission. Specifically, the researchers scrutinized records for terms associated with FNDs, confirming diagnoses through standardized clinical criteria and expert evaluations.

The study emphasized various parameters in its data extraction process, which were systematically categorized for analysis. These parameters included:

• Demographic information: Age at presentation and gender.
• Clinical details: Length of hospitalization, specific types of symptoms (such as motor or sensory deficits, seizures, or episodes of altered consciousness), and associated comorbidities.
• Treatment response: Interventions administered during hospitalization, including medications, psychiatric counseling, physical therapy, and any follow-up care recommendations upon discharge.

The analysis of comorbid conditions was particularly significant, as understanding accompanying diagnoses can illuminate the complexity of FNDs in children. This was achieved by reviewing prior medical histories recorded in the charts, looking for conditions such as anxiety disorders, depression, autism spectrum disorders, or other relevant psychological issues, which may influence the clinical management of FNDs.

To quantify symptom duration and recovery, the length of hospital stays was meticulously recorded. These records provided insights into the typical trajectories of care for FND presentations, highlighting not just the treatments received, but also the time needed for resolution of symptoms.

In terms of data management, statistical software was employed to conduct analyses and generate descriptive statistics, particularly focusing on central tendencies and distributions of the collected variables. The findings were subsequently organized into meaningful groups to facilitate comparisons and draw out key insights about the population’s characteristics.

Overall, this rigorous methodology aims to ensure that the findings are robust and reflective of the realities faced in clinical pediatric settings, allowing for an analysis of the effectiveness of current treatment approaches while identifying potential areas for improvement in the care of young patients with FNDs.

Key Findings

The analysis of the data collected revealed several significant findings that contribute to the understanding of functional neurological disorders (FNDs) in the pediatric population. A total of 150 patients were included in the study, providing insights into both the demographics and clinical characteristics of children and adolescents experiencing FNDs during hospitalization.

The cohort was predominantly female, comprising 60% of the total population, while males accounted for 40%. The average age at which patients presented with FND symptoms was approximately 12 years, with a broad range from infancy to 18 years. This distribution indicates that FNDs can manifest at various developmental stages, emphasizing the need for age-appropriate diagnostic and therapeutic approaches.

The types of symptoms reported were varied, but the most prevalent included motor dysfunction, such as weakness or abnormal movements (accounting for 45% of cases), followed by sensory disturbances (25%), seizures without a neurological basis (15%), and episodes resembling behavioral disorders (15%). These symptom profiles highlight the diverse presentations of FNDs in a pediatric setting.

Hospitalization durations averaged 10 days, with a range of 3 to 30 days. The length of stay depended significantly on the type and severity of symptoms presented. For instance, patients with predominant motor symptoms tended to have longer hospital stays, averaging 12 days, compared to those with sensory symptoms, who averaged 8 days. Moreover, a notable subset of patients requiring intensive psychiatric intervention extended their stays, reinforcing the correlation between mental health needs and the management of FNDs.

Comorbidities were frequently identified, with 35% of the patients having at least one additional psychological disorder documented, including anxiety disorders, attention-deficit/hyperactivity disorder (ADHD), and depressive conditions. This multifaceted presentation underscores the interactions between psychological health and FNDs, advocating for a comprehensive assessment and potential interdisciplinary treatment strategies.

The initial treatment protocols varied across the cohort but typically involved a combination of symptomatic management and therapeutic interventions. All patients received neurological evaluations, with 80% also receiving psychological support during their hospitalization. This multidisciplinary approach appeared effective; approximately 70% of the cohort showed a significant improvement in symptoms by the time of discharge. Specifically, 50% of those with motor symptoms exhibited notable recovery, whereas success rates for seizure-like episodes were slightly lower at around 60%.

Overall, these findings demonstrate not only the complexity and variability of FND presentations in hospitalized children and adolescents but also the importance of individualized patient care plans that incorporate both neurological and psychological aspects. The data collected serves as a crucial step in better defining the nature of FNDs in pediatric patients and optimizing treatment pathways for this vulnerable population.

Strengths and Limitations

The investigation into functional neurological disorders (FNDs) in the pediatric population presents notable strengths and limitations that merit consideration. One of the significant strengths of this study is its reliance on a robust retrospective cohort design. By utilizing existing medical records from a single pediatric hospital, the study was able to compile a substantial sample size of 150 patients, facilitating a more comprehensive understanding of FNDs within a specific healthcare setting. This method allows for reflection on actual clinical practices and patient characteristics that may not be fully captured in prospective studies.

Another noteworthy strength is the detailed data extraction process, which included not only demographic information but also clinical details and treatment responses. By systematically gathering information on symptom types, hospital stay durations, and comorbidities, the researchers could offer a nuanced portrait of this complex patient group. This thorough approach underscores the multifaceted nature of FNDs and highlights the interplay between neurological symptoms and psychological health, which is paramount in pediatric care.

Additionally, the study’s emphasis on interdisciplinary treatment approaches stands out as a significant strength. The findings indicate a high rate of improvement in symptoms, particularly when patients received both neurological and psychological support. This suggests that a coordinated management strategy may be critical for effective treatment and recovery in pediatric patients experiencing FNDs.

However, there are inherent limitations to consider. One limitation of the retrospective design is the potential for selection bias. Since the data were sourced from a single institution, the findings may not be generalizable to other healthcare settings where clinical practices and demographic profiles differ. Variability in diagnostic criteria and treatment protocols across institutions could affect the prevalence rates and treatment efficacy observed in this study.

Another limitation is the reliance on historical medical records, which might be incomplete or inconsistently recorded. This can lead to gaps in data concerning symptom onset, prior treatments, and comorbid conditions. As a result, facets of the patients’ medical histories that could provide deeper context may not have been captured adequately, potentially influencing the overall interpretation of findings.

The retrospective nature of the study also precludes the ability to establish causal relationships between the various factors assessed. While correlations can be identified, the lack of a control group and the observational design mean that definitive conclusions regarding treatment efficacy or the natural history of FNDs cannot be drawn.

Lastly, the study did not explore long-term outcomes following hospitalization. Understanding the trajectory of FNDs after discharge is essential for developing effective long-term management strategies. Without this information, the findings may only reflect short-term improvements while overlooking the potential for symptom relapse or chronicity in this populations.